Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

North America, California, United States, Carlsbad

Description

Ionis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs.

Investor Profile

Ionis Pharmaceuticals has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical, Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ionis Pharmaceuticals frequently co-invest with?

Ridgeback Capital
North America, New York, United States, New York
Co-Investments: 1
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 1
BioMotiv
North America, Ohio, United States, Cleveland
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
CH
North America, New York, United States, New York
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 1
Neotribe Ventures
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Ionis Pharmaceuticals?

Aro Biotherapeutics

Philadelphia, Pennsylvania, United States

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series AJan 5, 2021
Amount Raised: $88,000,000
Empirico

San Diego, California, United States

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

BiotechnologyLife ScienceMedical
Series AJan 9, 2020
Amount Raised: $17,000,000